Medication adherence to sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists: A meta-analysis.

Conner E JohnsonWhitney B SussmanErin R Weeda

Published in: Diabetes, obesity & metabolism (2024)

In this meta-analysis of eight studies that included approximately 200 000 patients, there was no difference in adherence to SGLT2is versus GLP-1RAs. However, SGLT2i use was associated with higher adherence when the analysis was limited to US studies.

Keyphrases

case control
systematic review
end stage renal disease
newly diagnosed
chronic kidney disease
type diabetes
randomized controlled trial
adipose tissue
skeletal muscle
metabolic syndrome
weight loss
wild type